Wealth Enhancement Advisory Services
RVMD icon

Wealth Enhancement Advisory Services’s Revolution Medicines RVMD Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.47M Buy
+14,600
New +$2.13M ﹤0.01% 1439
2026
Q1 		– Sell
-2,604
Closed -$208K – 3828
2025
Q4 		$208K Buy
+2,604
New +$171K ﹤0.01% 3247

Other funds holding RVMD

Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
WPC
Wedmont Private Capital West Chester, Pennsylvania $3.65B AUM 26.64% 1-Year Est. Return
SCA
Sandy Cove Advisors Hingham, Massachusetts $400M AUM 27.68% 1-Year Est. Return
SWM
Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
CPM
Connective Portfolio Management New York $60.1M AUM 88.93% 1-Year Est. Return
EOJOAM
E. Ohman J:or Asset Management Stockholm, Sweden $4.3B AUM 29.55% 1-Year Est. Return
P
PensionDanmark Copenhagen O, Denmark $12B AUM

Wealth Enhancement Advisory Services's RVMD Position: Q2 2026 in Review

Wealth Enhancement Advisory Services opened a new position in Revolution Medicines (RVMD) in Q2 2026: 14,600 shares worth $2.47M. The stake represents ﹤0.01% of the portfolio and ranks #1439 among its holdings. This is a return to the name: Wealth Enhancement Advisory Services previously reported a position in RVMD as recently as Q4 2025.

Wealth Enhancement Advisory Services first reported a position in RVMD in Q4 2025 and has held it in 2 quarters since. 59 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Wealth Enhancement Advisory Services held 14,600 shares of Revolution Medicines worth $2.47M as of Q2 2026.
  • Revolution Medicines was a new Wealth Enhancement Advisory Services position in Q2 2026.
  • Revolution Medicines made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #1439 holding.
  • Wealth Enhancement Advisory Services first reported a position in Revolution Medicines in Q4 2025 and has held it in 2 quarters since.
  • 59 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.